Steven R. Goldstein

Azure Biotech is a private, newly formed biotechnology company that has acquired rights for the development of a novel formulation of lasofoxifene targeting an underserved market in women's health from Ligand Pharmaceuticals. The Azure team is uniquely qualified to bring lasofoxifene forward for targeted new indications and formulations.